High RORA expression was proved as an independent favorable factor for OS and correlated with numerous immune checkpoint-related genes such as CD274 and PDCD1LG2 in NSCLC patients (Xian et al., 2022). This evidence concerns the gene RORA and non-small cell lung carcinoma.